Scientists have pioneered a groundbreaking method to combat snake venom using newly designed proteins, offering hope for more effective, accessible, and affordable antivenom solutions.
By utilizing advanced computational techniques and deep learning, this innovative approach has already shown promising results in neutralizing deadly toxins, potentially transforming antivenom development, and offering new strategies for tackling other neglected diseases.
Breakthrough in Antivenom Research
Scientists have designed new proteins — unlike any found in nature — that can neutralize some of the most toxic components of snake venom. Using advanced deep learning and computational methods, researchers have developed these proteins with the potential to create safer, more affordable, and widely accessible treatments compared to existing antivenoms.
Each year, over 2 million people suffer from snakebites, with more than 100,000 deaths and 300,000 cases of severe complications, including limb deformities, amputations, and other long-term disabilities, according to the World Health Organization. The highest burden of snakebites is seen in regions such as Sub-Saharan Africa, South Asia, Papua New Guinea, and Latin America, where access to effective treatment is often limited.
Advancements in Computational Biology
This groundbreaking computational biology research, aimed at improving antivenom therapies, was led by scientists from the UW Medicine Institute for Protein Design and the Technical University of Denmark. Their findings were published in Nature on January 15.
The lead author of the paper is Susana Vazquez Torres of the Department of Biochemistry at the UW School of Medicine and the UW Graduate Program in Biological Physics. Her hometown is Querétaro, Mexico, which is located near viper and rattlesnake habitats. Her professional goal is to invent new drugs for neglected diseases and injuries, including snakebites.
The Challenge of Elapid Snakebites
Her research team, which also included international experts in snakebite research, drugs and diagnostics, and tropical medicine from the United Kingdom and Denmark, concentrated their attention on finding ways to neutralize venom gathered from certain elapids. Elapids are a large group of poisonous snakes, among them cobras and mambas, that live in the tropics and subtropics.
Most elapid species have two small fangs shaped like shallow needles. During a tenacious bite, the fangs can inject venom from glands at the back of the snake's jaw. Among the venom's components are potentially lethal three-finger toxins. These chemicals damage bodily tissues by killing cells. More seriously, by interrupting signals between nerves and muscles, three-finger toxins can cause paralysis and death.
Limitations of Current Treatments
At present, venomous snakebites from elapids are treated with antibodies taken from the plasma of animals that have been immunized against the snake toxin. Producing the antibodies is costly, and they have limited effectiveness against three-finger toxins. This treatment can also have serious side effects, including causing the patient to go into shock or respiratory distress.
"Efforts to try to develop new drugs have been slow and laborious," noted Vazquez Torres.
Innovations in Protein Design
The researchers used deep learning computational methods to try to speed the discovery of better treatments. They created new proteins that interfered with the neurotoxic and cell-destroying properties of the three-finger toxin chemicals by binding with them.
Through experimental screening, the scientists obtained designs that generated proteins with thermal stability and high binding affinity. The actual synthesized proteins were almost a complete match at the atomic level with the deep-learning computer design.
In lab dishes, the designed proteins effectively neutralized all three of the subfamilies of three-finger toxins tested. When given to mice, the designed proteins protected the animals from what could have been a lethal neurotoxin exposure.
Promising Results and Future Directions
Designed proteins have key advantages. They could be manufactured with consistent quality through recombinant DNA technologies instead of by immunizing animals. (Recombinant DNA technologies in this case refer to the lab methods the scientists employed to take a computationally designed blueprint for a new protein and synthesize that protein.)
Also, the new proteins designed against snake toxins are small, compared to antibodies. Their smaller size might allow for greater penetration into tissues to quickly counteract the toxins and reduce damage.
Expanding the Potential of Computational Design
In addition to opening new avenues to develop antivenoms, the researchers think computational design methods could be used to develop other antidotes. Such methods also might be used to discover medications for undertreated illnesses that affect countries with significantly limited scientific research resources.
"Computational design methodology could substantially reduce the costs and resource requirements for development of therapies for neglected tropical diseases," the researchers noted.
Explore Further: AI Triumphs Over Venom: Revolutionary Snakebite Antidotes Unveiled
Reference: "De novo designed proteins neutralize lethal snake venom toxins" by Susana Vázquez Torres, Melisa Benard Valle, Stephen P. Mackessy, Stefanie K. Menzies, Nicholas R. Casewell, Shirin Ahmadi, Nick J. Burlet, Edin Muratspahić, Isaac Sappington, Max D. Overath, Esperanza Rivera-de-Torre, Jann Ledergerber, Andreas H. Laustsen, Kim Boddum, Asim K. Bera, Alex Kang, Evans Brackenbrough, Iara A. Cardoso, Edouard P. Crittenden, Rebecca J. Edge, Justin Decarreau, Robert J. Ragotte, Arvind S. Pillai, Mohamad Abedi, Hannah L. Han, Stacey R. Gerben, Analisa Murray, Rebecca Skotheim, Lynda Stuart, Lance Stewart, Thomas J. A. Fryer, Timothy P. Jenkins and David Baker, 15 January 2025, Nature.
DOI: 10.1038/s41586-024-08393-x
The senior researchers on the project to design protein treatments for elapid snakebites were Timothy J. Perkins at the Technical University of Denmark and David Baker of the UW Medicine Institute for Protein Design and the Howard Hughes Medical Institute. Baker is a professor of biochemistry at the UW School of Medicine.
The University of Washington has submitted a provisional U.S. patent application for the design and composition of the proteins created in this study.
News
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
